Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068370
Filing Date
2014-11-14
Accepted
2014-11-14 11:36:29
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393384_10q.htm 10-Q 370503
2 EXHIBIT 31.1 v393384_ex31-1.htm EX-31.1 9915
3 EXHIBIT 31.2 v393384_ex31-2.htm EX-31.2 9862
4 EXHIBIT 32 v393384_ex32.htm EX-32 3536
  Complete submission text file 0001144204-14-068370.txt   3606805

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clcs-20140930.xml EX-101.INS 551230
6 XBRL TAXONOMY EXTENSION SCHEMA clcs-20140930.xsd EX-101.SCH 29696
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20140930_cal.xml EX-101.CAL 21905
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20140930_def.xml EX-101.DEF 159518
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20140930_lab.xml EX-101.LAB 206392
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20140930_pre.xml EX-101.PRE 196487
Mailing Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128 18889709463
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-187049 | Film No.: 141221702
SIC: 2834 Pharmaceutical Preparations